Coronavirus in Gastroenterology, Hepatology and Inflammatory Bowel Disease

Against the Grain

Today we are going to tackle Coronavirus, specifically SARS-CoV-2 which causes the disease COVID 19 in relation to gastrointestinal symptoms and disease. I will be interviewing Dr Kaushal Majmudar who is one of our great GI fellows at Advocate Lutheran General Hospital. He recently did a Grand Rounds for our GI department on this very topic and went over all the recent data regarding pathogenesis, treatment and also recommendations from various GI societies for specific clinical scenarios regarding liver disease, endoscopy and inflammatory bowel disease. This will be valuable information for clinicians in all specialties and definitely for those working in GI. Though at times this does become technical at certain points, it will be valuable information for the non-physician audience too. At the end I will give my own thoughts about COVID 19 and IBD with comments on the relevance of the hygiene hypothesis, infusion centers and specific risks of medications. As a disclaimer, we are not the CDC or members of committees creating the guidelines that will be discussed. Opinions are our own. This is an open discussion and should not be interpreted as medical advice.